Term
multiple sclerosis immune mechanism |
|
Definition
o Type IV Hypersensitivity—delayed-type hypersensitivity; depends on T cells |
|
|
Term
|
Definition
• IL-2 is especially important for the development and maintenance of *** |
|
|
Term
|
Definition
pathogens present an epitope that is similar to self-epitope; cross-activates autoreactive T cells |
|
|
Term
|
Definition
activation of T cells specific for an antigen X during an immune response against antigen Y |
|
|
Term
Tumor Necrosis Factor alpha (TNF-alpha) |
|
Definition
stimulates acute phase inflammation • A local increase in concentration of this will cause the cardinal signs of Inflammation to occur: heat, swelling, redness, and pain. • Macrophages produce more *** than T cells |
|
|
Term
|
Definition
CD4+ TH1 produce ***, activates macrophages. Macrophages produce TNF-alpha |
|
|
Term
|
Definition
o CD4+ TH17 produce ***, promotes inflammation (with TNF-alpha) |
|
|
Term
|
Definition
(binds ICAM-1 on endothelium) |
|
|
Term
|
Definition
(binds VCAM-1 on endothelium) |
|
|
Term
|
Definition
immunodiagnosis: CerebroSpinal Fluid (CSF) elevated IgG (high IgG/albumin ratio) |
|
|
Term
|
Definition
oligoclonal bands on protein electrophoresis (90% of patients) |
|
|
Term
|
Definition
• Glatiramir acetate (aka Copolymer I or Copaxone) • IFN-beta • Fingolimond (o Causes retention of lymphocytes in lymph nodes so they can’t go to CNS) • Mitoxantrone (Prevents DNA unwinding,Prohibits proliferation of immune cells) • Monoclonal antibody against VLA-4 (Alemtuzumab) (Reduces migration of lymphocytes across BBB) |
|
|
Term
• Guillain-Barre syndrome (GBS)— |
|
Definition
An acute immune-mediated demyelinating neuropathy (with ascending paralysis¬) in which peripheral nerves are infiltrated with lymphocytes & macrophages |
|
|
Term
• Guillain-Barre syndrome (GBS) dx |
|
Definition
Anti-GM1 & anti-GD1 auto-antibodies In CSF: Elevated protein (due to inflammation), Oligoclonal bands may be present |
|
|
Term
|
Definition
Elevated protein in CSF (due to inflammation) No auto-antibodies Oligoclonal bands are not regularly found |
|
|
Term
myasthenia gravis immune mechanism |
|
Definition
o Type II hypersensitivity Auto-antibodies against acetylcholine receptor (AChR) Classical pathway: complement binds to antibodies Affects post-synaptic membrane anti-cholinesterase drugs can help |
|
|
Term
Lambert-Eaton immune mechanism |
|
Definition
o Type II hypersensitivity Auto-antibody against voltage-gated calcium channels Affects pre-synaptic membrane anti-cholinesterase drugs do not help |
|
|
Term
• Lambert-Eaton myasthenic syndrome |
|
Definition
a disease of the neuromuscular junction, characterized by proximal muscle weakness and difficulty walking |
|
|
Term
|
Definition
—a disease of the neuromuscular junction, characterized by generalized muscle weakness & fatigue of voluntary muscles due to impared neurotransmission, caused by auto-antibody-mediated loss of actylcholine receptors |
|
|
Term
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Immune mechanisms |
|
Definition
Type IV hypersensitivity • Myelin-specific CD4+ TH1 cellsproduct IFN-gammaactivate macrophagescause demyelination • Caused by infection Type II hypersensitivity • Auto-antibodies from B cells may also contribute to disease process But, it is rarely preceded by infection |
|
|
Term
• Guillain-Barre syndrome (GBS)— immune mechanisms |
|
Definition
Type IV hypersensitivity • Myelin-specific CD4+ TH1 cellsproduct IFN-gammaactivate macrophagescauase demyelination • Caused by infection Type II hypersensitivity • Auto-antibodies from B cells may also contribute to disease process |
|
|
Term
|
Definition
o Type IV Hypersensitivity—delayed-type hypersensitivity; depends on T cells o Immune reaction to myelin antigens. |
|
|
Term
|
Definition
chronic inflammation of the muscles, seen mostly in adults o Causes is unclear o Muscle damage may be caused by CD8+ CTLs |
|
|
Term
|
Definition
chronic inflammation of the muscles and skin; involves distinctive skin rashes, including discoloration of the eyelids. o Cause is unclear r o Type II (cyotoxic) or type III hypersensitivity (immune complex) |
|
|
Term
|
Definition
• anti-Jo 1 (anti-histidyl transfer RNA synthetase) o auto-antibody seen in ** • anti-SRP (anti-signal recognition particle) o auto-antibody seen in ** |
|
|
Term
|
Definition
• anti-Mi-2 (anti-Mi-2 nuclear antigen) o autoantibody seen in ** |
|
|
Term
|
Definition
can be caused by small cell carcinoma of the lungs |
|
|